3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and 22q11 Deletion Syndrome

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with 22q11 Deletion Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baas, F; Booij, J; Boot, E; de Haan, L; Linszen, DH; van Amelsvoort, TA; Zinkstok, JR	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and 22q11 Deletion Syndrome

Article	Year
Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:10 Topics: 22q11 Deletion Syndrome; Adolescent; Adult; Benzamides; Cognition Disorders; Corpus Striatum; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Organ Specificity; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Severity of Illness Index; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon; Young Adult	2010

Article

Year

Striatal D₂ receptor binding in 22q11 deletion syndrome: an [¹²³I]IBZM SPECT study.

Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:10

Topics: 22q11 Deletion Syndrome; Adolescent; Adult; Benzamides; Cognition Disorders; Corpus Striatum; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Organ Specificity; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Severity of Illness Index; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon; Young Adult

2010